DCCPS By The Numbers
As a window into the many ways DCCPS provides return on investment, we highlight here some snapshots of progress over the year.
In recent years, DCCPS has seen a tremendous increase in the number of health disparities and health equity grants within the division’s overall portfolio. In FY 2022, 73% of the division’s funded awards included a health disparities component.
Thirteen administrative supplements were awarded to NCI-Designated Cancer Centers in FY 2022 to study the feasibility of implementing standardized sexual orientation and gender identity (SOGI) measures recommended by the National Academies of Sciences, Engineering, and Medicine (NASEM).
There are 1,952 publications currently included in DCCPS’s Native American Cancer Control Literature Database, a compilation of published scientific literature on cancer-related topics with Native American communities, including American Indian, Alaska Native, Native Hawaiian, and First Nations populations.
In FY 2022, more than 65,000 smoking and vaping quit plans were created on Smokefree.gov’s and Smokefree Teen’s Build My Quit Plan pages. These interactive web-based tools help people create a personalized plan for quitting tobacco and connect them with digital and telephone smoking cessation resources.
More than 12,500 data users have utilized the Health Information National Trends Survey® (HINTS), which monitors changes in the rapidly evolving fields of health communication and health information technology. As of September 2022, 728 publications in 266 peer-reviewed journals had used data from the publicly accessible resource.
Across 15 survey administrations, HINTS has surveyed more than 60,000 American adults, tracking shifts in the communication landscape and information support needs in the population.
In August 2022, NCI launched its Cancer Moonshot Telehealth Research Centers of Excellence (TRACE) Program, focused on evaluating the use of telehealth in improving cancer-related care and outcomes across the cancer continuum. NCI is investing $23 million over 5 years (2022–2027) to support four academic research institutions conducting research in the use of telehealth in real-world clinical settings.
From January to September 2022, the National Collaborative on Childhood Obesity Research (NCCOR) website received 1.2 million page views. NCCOR is a collaboration among NIH and the Centers for Disease Control and Prevention, US Department of Agriculture (USDA), and Robert Wood Johnson Foundation to accelerate progress in reducing childhood obesity for all children, with particular attention to high-risk populations and communities.
The division is deeply committed to building a diverse health sciences workforce that maintains, fosters, and promotes an equitable, inclusive, accessible, and nurturing work environment. Of the current fellows in DCCPS, 44% reported identifying from racially and ethnically diverse backgrounds.
DCCPS published the 23rd volume in the Tobacco Control Monograph series, titled Treating Smoking in Cancer Patients: An Essential Component of Cancer Care. This monograph expands upon prior research to inform clinicians and their patients with cancer about the science and practice of quitting smoking. Since 1991, DCCPS has been producing monographs to provide comprehensive scientific reviews of tobacco use, treatment, and prevention topics to inform the work of researchers, clinicians, and public health practitioners and reduce cancer morbidity and mortality.
The current sample grant applications published by the Epidemiology and Genomics Research Program (EGRP) were downloaded more than 4,488 times in FY 2022.
The database of Genotypes and Phenotypes (dbGaP) at the National Center for Biotechnology Information (NCBI) archives datasets and makes them available to the scientific community. As of September 2022, 82 datasets from DCCPS-funded studies can be accessed through dbGaP.
The Cancer Epidemiology Descriptive Cohort Database (CEDCD) contains descriptive information from over 60 cohorts with participants from 20 different countries. CEDCD includes brief descriptions of the cohorts, contact information, questionnaires, types of data collected, enrollment numbers, number of cancer cases, and number of biospecimens collected. Its purpose is to foster collaboration and encourage cohort-based research. In the past year, CEDCD was accessed more than 3,000 times, with over 2,500 new users.
Since the Automated Self-Administered 24-Hour (ASA24®) Dietary Assessment Tool was released in 2009, researchers have collected 799,434 dietary recalls or food records.
On average, 76 new studies register to use ASA24 every month. As of September 2022, there were more than 600 peer-reviewed scientific studies published that used ASA24 to collect diet data.
The NCI Cohort Consortium currently comprises 68 cancer etiology and cancer survivor cohorts located in North America, Europe, Asia, and Australia, representing approximately 7 million participants. Over 70 collaborative projects have led to scientific discoveries about cancer risk factors and advances in epidemiologic methodologies.
The Healthy Eating Index (HEI)–2015 is a valuable tool for surveillance, epidemiology, and intervention research and has been cited in over 275 articles since its release in 2018. Scientists in DCCPS and USDA collaborated to create the HEI, a measure of diet quality that can be used to assess compliance with the Dietary Guidelines for Americans and to monitor diet quality across the life course. The HEI–2015 SAS code been downloaded 6,287 times since 2018.
Over 559,000 SEER cases have been linked to Medicaid data. The SEER-Medicaid data linkage provides valuable information about Medicaid beneficiaries with cancer.
There were 822 attendees in Healthcare Delivery Research Program (HDRP)-led webinars on addressing social risks in cancer care delivery.
Forty-three language translations have been validated—and 23 more are in development as of October 2022—for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™), a patient-reported outcome measurement system developed by NCI to capture symptomatic adverse events in patients on cancer clinical trials. A pediatric module for use with children and adolescents (or their caregivers if the child is unable to self-report) is also available. The pediatric module is currently available in English, Italian, and Simplified Chinese, and seven other languages are currently being tested, including Spanish, German, Korean, Danish, and French.
The NCI Community Oncology Research Program (NCORP) is a national network that brings cancer prevention, control, and cancer care delivery research studies to people in their communities. Seven research bases develop and coordinate clinical trials and cancer care delivery research for 14 minority or underserved community sites and 32 community sites to bring NCI-approved trials to patients in 1,000+ locations in diverse, community-based hospitals, private practices, and other locations.
There were 745 attendees for the short course “Cluster Randomized Trial Designs in Cancer Care Delivery Research,” which provided training in the design, conduct, and analysis of cluster randomized trials.
In FY 2022, more than 1.5 million clients were served by 912 innovation laboratory sites across seven Implementation Science Centers in Cancer Control (ISC3).
The ISC3 trained more than 2,000 participants through 70 capacity-building workshops in FY 2022.
The Comprehensive Cancer Control National Partnership (CCCNP) joins together 17 partner organizations, including NCI. Through coordination and collaboration, the partnership assists comprehensive cancer control (CCC) coalitions in developing and sustaining implementation of CCC plans at the state, tribe, territory, US Pacific Island jurisdiction, and local levels.
In FY 2022, there were 12 awards issued to Consortium for Cancer Implementation Science (CCIS) participants for the development of implementation science public goods to advance implementation science in cancer control.
The NCI Office of Cancer Survivorship Director’s Series began in September 2021. There were 2,415 people registered in FY 2022, the series’ first full year.
From 2017 to 2021, DCCPS funded 44 early-stage investigators for cancer survivorship research.